United Kingdom

Santen Pharmaceutical Co Ltd (4536.T)

4536.T on Tokyo Stock Exchange

22 Jan 2018
Change (% chg)

¥23 (+1.31%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Akira Kurokawa

64 2008 President, Chief Executive Officer, Representative Director

Kazuo Koshiji

2017 Chief Financial Officer, Managing Executive Officer, Chief Director of Finance

Noriaki Yamamoto

Chief Information Officer, Executive Officer, Chief Director of Information System

Naveed Shams

2017 Chief Scientific Officer, Managing Executive Officer, Chief Director of Research & Development

Masamichi Sato

2017 Managing Executive Officer, Chief Compliance Officer, Chief Director of CSR & Internal Control, President of Subsidiary